1. Uhrbrand, L., Faurbye, A. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy. Psychopharmacologia (Berl.), 1:408–418, 1960.
2. Faurbye, A., Rasch, R.J., Petersen, P.B., Brandborg, G., Pakkenberg, H. Neurological symptoms in pharmacotherapy of psychosis. Acta Psychiatr. Scand., 40:10–27, 1964.
3. Gerlach, J., Simmelsgaard, H. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine and clozapine. Psychopharmacology. (In press).
4. Gerlach, J., Thorsen, K., Fog, R. Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacologia (Berl.), 40:341–350, 1975.
5. Gerlach, J., Reisby, N., Randrup, A. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia (Berl.), 34:21–35, 1974.